ethnopharmacolog
relev
isatidi
radix
sundri
root
isati
indigotica
fortun
ex
lindl
one
usual
use
tradit
chines
medicin
centuri
herb
employ
clinic
practic
treatment
viru
infect
inflamm
howev
activ
ingredi
remain
unclear
aim
studi
present
studi
antiinfluenza
viru
activ
epiprogoitrin
progoitrin
epigoitrin
goitrin
isatidi
radix
deriv
glucosinol
isom
breakdown
product
firstli
evalu
vitro
ovo
mechan
action
investig
materi
method
epiprogoitrin
progoitrin
epigoitrin
goitrin
isol
isatidi
radix
chiral
separ
vitro
ovo
evalu
perform
madindarbi
canin
kidney
mdck
cell
embryon
egg
respect
use
protocol
includ
prevent
treatment
viru
neutral
hemagglutin
ha
neuraminidas
na
inhibit
assay
perform
understand
antivir
mechan
result
isatidi
radix
deriv
glucosinol
isom
breakdown
product
exhibit
dosedepend
inhibit
effect
influenza
viru
without
toxic
antivir
potenc
compon
order
progoitrin
goitrin
epigoitrin
epiprogoitrin
attach
constitu
viral
envelop
conduc
mechan
antivir
action
without
disturb
viral
adsorpt
bud
conclus
taken
togeth
result
promis
develop
isatidi
radix
may
contribut
adjunct
pharmacotherapi
influenza
viru
infect
influenza
virus
envelop
rna
virus
caus
morbid
even
mortal
human
season
pandem
infect
annual
influenza
epidem
lead
fatal
case
global
courtin
et
al
current
therapeut
strategi
lower
mortal
rate
mainli
reli
vaccin
chemic
drug
usag
vaccin
often
challeng
frequent
mutat
antigen
narrow
spectrum
tao
et
al
zarubaev
et
al
side
viral
resist
advers
effect
restrict
clinic
applic
current
avail
antiinfluenza
viru
drug
includ
neuraminidas
inhibitor
channel
blocker
rna
synthesi
inhibitor
hayden
de
jong
samson
et
al
correia
et
al
henc
altern
drug
low
toxic
broad
spectrum
less
resist
remain
develop
ethnic
medicin
valuabl
heritag
commerci
import
resourc
prevent
treatment
viral
infecti
diseas
grow
number
accumul
evid
experiment
andor
clinic
efficaci
li
peng
lia
et
al
among
isatidi
radix
banlangen
chines
sundri
root
isati
indigotica
fortun
ex
lindl
wellknown
antivir
activ
ethnic
medic
practic
isatidi
radix
prescrib
treat
fever
pestil
sore
throat
season
toxin
papul
caus
warm
toxin
macula
scarlatina
mump
swell
abscess
erysipela
erysipela
faciali
chines
pharmacopoeia
commiss
offici
approv
medicin
materi
product
china
isatidi
radix
formul
use
major
herbal
remedi
prevent
treatment
wide
rang
viral
infect
lin
et
al
deng
et
al
regardless
variou
subtyp
virus
rapid
mutat
isatidi
radix
found
effect
clinic
infect
caus
influenza
virus
differ
strain
subtyp
ke
et
al
notwithstand
antiinfluenza
efficaci
isatidi
radix
prepar
well
acknowledg
activ
constitu
pharmacolog
action
elucid
far
antivir
compon
identifi
isatidi
radix
includ
quinazolinon
glycoprotein
yamada
epigoitrin
quinazolinedion
xu
et
al
indirubin
mak
et
al
fructopyrano
glucopyranos
zhang
et
al
clemastanin
b
li
et
al
polysaccharid
li
et
al
isatithioetherin
b
isatithioetherin
guo
et
al
among
antivir
monom
epigoitrin
receiv
much
attent
chosen
marker
antivir
efficaci
isatidi
radix
draft
edit
chines
pharmacopoeia
previou
studi
author
socal
epigoitrin
use
former
report
xu
et
al
ye
et
al
zhang
et
al
found
mixtur
unequ
amount
epigoitrin
r
goitrin
r
goitrin
goitrin
fact
isom
could
separ
regular
c
column
consequ
assay
marker
isatidi
radix
chang
r
goitrin
edit
chines
pharmacopoeia
addit
r
goitrin
first
resolv
author
nie
et
al
use
normal
phase
liquid
chromatographi
nplc
later
novel
supercrit
fluid
chromatographi
sfc
high
perform
liquid
chromatographi
hplc
method
develop
highthroughput
chiral
separ
stereospecif
assay
respect
nie
et
al
nie
et
al
hand
epigoitrin
goitrin
verifi
breakdown
product
glucosinol
prototyp
epiprogoitrin
r
progoitrin
effect
myrosinas
fig
nie
et
al
xie
et
al
well
isom
pure
enantiomer
form
epiprogoitrin
progoitrin
extract
resolv
author
isatidi
radix
spite
chemic
structur
biotransform
glucosinol
breakdown
product
illumin
xie
et
al
antivir
activ
monom
mode
action
remain
elus
current
studi
aim
go
compar
investig
antiinfluenza
activ
individu
glucosinol
breakdown
product
vitro
ovo
moreov
mechanist
studi
conduct
find
antivir
target
mode
action
isatidi
radix
banlangen
chines
isatidi
root
english
sundri
root
isati
indigotica
fortun
ex
lindl
scientif
name
plant
check
http
www
theplantlistorg
august
plant
materi
grown
good
agricultur
practic
gap
base
yutian
hebei
provinc
obtain
beij
tongrentang
co
ltd
origin
authent
associ
professor
shuai
kang
curat
tradit
chines
medicin
herbarium
nation
institut
food
drug
control
use
macroscop
microscop
analysi
accord
chines
pharmacopoeia
chines
pharmacopoeia
commiss
futur
refer
specimen
deposit
tradit
chines
medicin
herbarium
nation
institut
food
drug
control
beij
pr
china
epiprogoitrin
progoitrin
extract
isol
form
isatidi
radix
base
similar
strategi
previou
report
xie
et
al
first
pulver
isatidi
radix
extract
methanol
extract
deprotein
ammonium
acet
purifi
granular
activ
carbon
obtain
crude
extract
glucosinol
final
epiprogoitrin
progoitrin
separ
crude
extract
prepar
ionpair
chromatographi
epigoitrin
goitrin
separ
r
goitrin
refer
standard
nation
institut
food
drug
control
lot
sfc
chiral
resolut
chiralpak
ic
column
acetonitril
carbon
dioxid
mobil
phase
nie
et
al
structur
purifi
compound
confirm
h
c
nmr
bruker
ms
water
synapt
optic
rotat
rudolph
autopol
iv
puriti
prepar
compound
determin
hplc
xie
et
al
chiral
sfc
nie
et
al
method
content
epiprogoitrin
progoitrin
epigoitrin
goitrin
plant
materi
determin
respect
hplc
method
nie
et
al
xie
et
al
epiprogoitrin
progoitrin
epigoitrin
goitrin
dissolv
ml
dimethyl
sulfoxid
dmso
dilut
sodium
chlorid
inject
get
test
solut
concentr
solut
kept
steril
contain
influenza
viru
strain
nymc
shanghai
institut
biolog
product
co
ltd
continu
madindarbi
canin
kidney
mdck
cell
maintain
fetal
bovin
serum
fb
free
dulbecco
modifi
eagl
medium
dmem
gibco
tpcktreat
trypsin
tendayold
specif
pathogen
free
spf
embryon
chicken
egg
beij
merial
laboratori
anim
technolog
co
ltd
clean
egg
fertil
incub
rel
humid
candl
everi
day
elimin
infertil
egg
dead
embryo
peramivir
guangzhou
nanxin
pharmaceut
co
ltd
use
refer
compound
reagent
use
studi
follow
sodium
chlorid
inject
shijiazhuang
siyao
co
ltd
phosphat
buffer
salin
pb
hyclon
dimethyl
sulfoxid
dmso
sigma
alsev
solut
ph
isoton
solut
glucos
trisodium
citrat
sodium
chlorid
citric
acid
doubledistil
water
suspens
leghorn
chicken
red
blood
cell
crbc
prepar
equal
volum
chicken
male
blood
alsev
solut
ph
mixtur
wash
pb
time
supernat
discard
appropri
amount
blood
erythrocyt
dilut
pb
prepar
erythrocyt
suspens
cell
count
dojindo
neuraminidas
inhibitor
screen
kit
beyotim
institut
biotechnolog
co
ltd
contain
ml
neuraminidas
ml
buffer
ml
fluoresc
substrat
ml
water
ammonium
acet
granular
activ
carbon
acetonitril
glucos
sodium
chlorid
trisodium
citrat
citric
acid
sinopharm
chemic
reagent
co
ltd
carbon
dioxid
chengweifeng
inc
deioniz
water
purifi
milliq
system
millipor
bedford
usa
cytotox
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
examin
cell
count
method
mdck
cell
cultur
plate
cellswel
h
cultur
supernat
replac
solut
contain
four
compon
variou
concentr
moll
six
duplic
use
concentr
incub
h
cultur
supernat
discard
dmem
ad
well
plate
incub
h
fluoresc
intens
record
micropl
spectrophotomet
gemini
em
molecular
devic
usa
nm
cell
surviv
rate
calcul
repres
cell
viabil
mdck
cell
inocul
influenza
viru
tissu
cultur
infect
dose
tcid
determin
accord
reedmuench
method
reed
assay
antivir
activ
epiprogoitrin
progoitrin
epigoitrin
goitrin
vitro
perform
use
cpe
method
mdck
cell
grown
cultur
plate
cellswel
h
identifi
probabl
affect
viral
life
cycl
cell
treat
viru
tcid
sampl
solut
variou
concentr
moll
use
three
differ
protocol
includ
prevent
treatment
viru
neutral
protocol
prevent
cell
preincub
sampl
solut
h
viral
adsorpt
cell
wash
pb
inocul
viru
h
without
compound
grown
h
protocol
treatment
cell
first
inocul
viru
h
wash
pb
cultur
compound
h
protocol
viru
neutral
sampl
solut
mix
viru
incub
room
temperatur
min
mixtur
ad
cell
cultur
h
day
incub
solut
discard
cell
wash
pb
dmem
ad
well
plate
incub
dark
h
absorb
read
nm
micropl
spectrophotomet
gemini
em
molecular
devic
usa
six
duplic
use
dilut
ratio
cell
control
withwithout
sampl
solut
viru
control
includ
inhibit
ratio
calcul
use
follow
formula
inhibit
activ
odsampl
odviru
odcellular
control
odviru
odsampl
optic
densiti
test
sampl
certain
concentr
odviru
optic
densiti
influenza
viru
control
odcellular
control
optic
densiti
normal
cell
inhibit
concentr
ic
determin
linear
extrapol
result
seriou
dose
test
assess
antivir
potenc
embryon
egg
viru
titrat
day
embryon
egg
inocul
influenza
viru
strain
egg
infect
dose
eid
calcul
use
reedmuench
method
reed
likewis
ovo
evalu
perform
use
three
differ
protocol
first
egg
pretreat
ml
sampl
solut
incub
h
administr
ml
viru
eid
second
egg
inocul
ml
viru
eid
h
administr
ml
sampl
solut
third
ml
viru
eid
ml
sampl
solut
incub
min
room
temperatur
mixtur
administ
egg
incub
h
harvest
egg
store
h
facilit
harvest
procedur
egg
decap
allanto
membran
care
move
side
pipett
upper
allanto
fluid
harvest
allanto
fluid
subject
hemagglutin
ha
test
ubottom
well
microtit
plate
label
horizont
dilut
use
multichannel
pipett
pb
ad
well
allanto
fluid
ad
first
well
row
pb
ad
last
row
twofold
dilut
made
transfer
first
well
column
done
last
column
remain
discard
leghorn
chicken
red
blood
cell
crbc
ad
well
mix
manual
agit
plate
thoroughli
plate
incub
min
room
temperatur
crbc
form
button
ring
bottom
well
record
neg
use
symbol
hemagglutin
occur
crbc
agglutin
immobil
consid
posit
record
use
symbol
highest
dilut
viru
caus
complet
hemagglutin
consid
endpoint
ha
titrat
result
record
accord
ha
effect
well
dilut
egg
still
aliv
score
surviv
egg
show
ha
activ
score
neg
epiprogoitrin
progoitrin
epigoitrin
goitrin
assess
variou
concentr
four
dose
level
mg
ml
differ
experi
viru
concentr
eid
mgml
peramivir
use
posit
control
sodium
chlorid
inject
use
neg
control
equal
dose
viru
dmso
set
viru
control
dilut
control
respect
shamoper
group
perform
well
egg
inocul
group
elucid
mode
antivir
action
inhibit
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
two
glycoprotein
viru
evalu
first
hai
assay
conduct
investig
inhibit
effect
compon
hemagglutinin
hemagglutin
ha
titrat
six
embryon
chicken
egg
inocul
ml
influenza
viru
strain
eid
incub
day
amnioallanto
fluid
aaf
harvest
live
embryo
dilut
pb
viru
replic
ha
assay
dilut
viral
solut
mix
equal
volum
suspens
leghorn
chicken
red
blood
cell
crbc
incub
undilut
viru
pb
use
posit
neg
control
respect
min
hemagglutin
titer
determin
highest
dilut
caus
complet
agglutin
ha
assay
label
hemagglutin
titer
viru
hemagglutin
inhibit
hai
assay
time
hemagglutin
titer
use
standard
hemagglutinin
viral
solut
dilut
mgml
stock
solut
epiprogoitrin
progoitrin
epigoitrin
goitrin
prepar
pb
respect
equal
volum
standard
hemagglutinin
viral
solut
sampl
solut
mix
gentli
incub
room
temperatur
min
standard
hemagglutinin
viral
solut
pb
use
posit
neg
control
respect
suspens
crbc
ad
mixtur
incub
min
final
hemagglutin
inhibit
effect
compon
observ
experi
perform
duplic
dilut
ratio
evalu
inhibit
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
neuraminidas
na
inhibit
assay
perform
micropl
reader
use
neuraminidas
inhibitor
screen
kit
well
reaction
buffer
na
sampl
solut
ad
reaction
mixtur
vibrat
min
incub
min
full
interact
fluoresc
substrat
ad
entir
mixtur
vibrat
min
incub
h
epiprogoitrin
progoitrin
epigoitrin
goitrin
dilut
water
prepar
sampl
solut
differ
concentr
mgml
peramivir
differ
concentr
mgml
use
posit
control
water
use
neg
control
triplic
use
dilut
ratio
fluoresc
record
micropl
spectrophotomet
gemini
em
molecular
devic
usa
excit
wavelength
emiss
wavelength
set
nm
nm
respect
inhibit
rate
calcul
follow
na
inhibitori
activ
f
f
f
f
f
fluoresc
intens
sampl
f
absorb
background
f
absorb
neg
control
experi
carri
triplic
data
present
mean
standard
deviat
valu
tcid
eid
ic
calcul
use
spss
softwar
result
cytotox
test
indic
epiprogoitrin
progoitrin
epigoitrin
goitrin
investig
concentr
show
influenc
cell
viabil
maximum
nontox
dose
isatidi
radix
deriv
glucosinol
isom
breakdown
product
mdck
cell
moll
cpe
assay
perform
dose
epiprogoitrin
progoitrin
epigoitrin
goitrin
evalu
antivir
activ
influenza
viru
strain
mdck
cell
via
cytopath
effect
cpe
inhibit
assay
mode
action
compon
studi
cell
pretreat
epiprogoitrin
progoitrin
epigoitrin
goitrin
viral
adsorpt
cell
treat
compon
viru
incub
obviou
protect
effect
observ
howev
cell
treat
prereact
viru
compon
pronounc
cpe
inhibit
effect
detect
epiprogoitrin
progoitrin
epigoitrin
goitrin
exhibit
dosedepend
antiinfluenza
viru
activ
ic
valu
respect
fig
agreement
result
vitro
test
epiprogoitrin
progoitrin
epigoitrin
goitrin
fail
exhibit
prevent
treatment
effect
influenza
viru
ovo
howev
chicken
embryo
treat
premix
solut
sampl
concentr
mgml
viru
allanto
fluid
show
ha
effect
crbc
shown
tabl
isatidi
radix
deriv
glucosinol
isom
breakdown
product
found
neutral
influenza
viru
dose
depend
manner
minimum
concentr
epiprogoitrin
progoitrin
epigoitrin
goitrin
exhibit
signific
inhibit
inhibit
rate
mgml
respect
minimum
investig
concentr
mgml
inhibit
rate
epiprogoitrin
progoitrin
epigoitrin
goitrin
respect
concentr
compon
found
safe
sampl
solut
differ
concentr
mix
viru
tcid
incub
room
temperatur
min
mixtur
ad
cell
incub
co
h
antivir
activ
investig
cytopath
effect
cpe
inhibit
assay
cell
count
method
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
hemagglutinin
inhibitori
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
hemagglutinin
examin
character
mode
antivir
action
shown
fig
hemagglutinin
inhibit
reaction
solut
use
posit
control
presenc
epiprogoitrin
progoitrin
epigoitrin
goitrin
even
highest
concentr
mgml
exhibit
antivir
activ
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
neuraminidas
na
regard
one
import
target
antiinfluenza
viru
activ
drug
shown
tabl
peramivir
present
dosedepend
na
inhibitori
activ
ic
valu
mgml
appar
inhibit
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
na
observ
even
highest
concentr
mgml
highli
contagi
diseas
influenza
caus
high
morbid
mortal
epidem
year
due
advers
effect
viral
resist
develop
novel
natur
antiinfluenza
drug
becom
necessari
urgent
isatidi
radix
use
age
cure
symptom
similar
influenza
report
show
satisfactori
efficaci
respiratori
virus
mechan
remain
unillumin
till
xu
et
al
differ
type
compound
isol
tradit
medicin
includ
alkaloid
lignan
flavonoid
etc
first
time
antivir
effect
mode
action
glucosinol
biotransform
product
isatidi
radix
discuss
studi
two
pair
enantiom
name
epiprogoitrin
progoitrin
epigoitrin
goitrin
prepar
isatidi
radix
chiral
separ
first
cpe
inhibit
assay
design
three
differ
way
examin
inhibitori
effect
influenza
viru
strain
vitro
determin
stage
act
viral
replic
cycl
result
indic
antivir
activ
epiprogoitrin
progoitrin
epigoitrin
goitrin
mainli
attribut
virucid
effect
action
host
cell
protect
postvirusadsorpt
interrupt
viru
rather
cell
probabl
action
target
compon
henc
insight
antivir
activ
ovo
perform
hemagglutin
test
allanto
fluid
embryon
egg
agreement
previou
observ
four
compon
found
significantli
reduc
viral
titer
chicken
embryo
mix
viru
infect
taken
togeth
conclud
epiprogoitrin
progoitrin
epigoitrin
goitrin
show
obviou
virucid
effect
influenza
viru
vitro
ovo
deeper
understand
mechan
antivir
action
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
hemagglutinin
neuraminidas
evalu
hemagglutin
inhibit
hai
assay
neuraminidas
inhibit
na
assay
influenza
viru
envelop
rna
viru
hemagglutinin
ha
fig
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
hemagglutinin
effect
epiprogoitrin
progoitrin
epigoitrin
goitrin
hemagglutinin
evalu
hemagglutin
inhibit
hai
assay
epiprogoitrin
progoitrin
epigoitrin
goitrin
concentr
mgml
serial
dilut
ad
plate
standard
hemagglutinin
viral
solut
ad
plate
chicken
red
blood
cell
suspens
ad
mixtur
describ
materi
method
interpret
refer
colour
figur
legend
reader
refer
web
version
articl
neuraminidas
na
embed
lipid
envelop
viral
adsorpt
cell
initi
step
influenza
infect
perform
via
bind
sialic
acid
cell
surfac
hemagglutinin
viru
skehel
wiley
result
hai
assay
show
exposur
epiprogoitrin
progoitrin
epigoitrin
goitrin
affect
hemagglutinin
activ
viru
compon
indic
interfer
bind
sialic
acid
hemagglutinin
hand
releas
influenza
viru
cell
na
function
enzym
cleav
sialic
acid
group
host
glycoprotein
huang
et
al
epiprogoitrin
progoitrin
epigoitrin
goitrin
found
exert
low
inhibit
rate
neuraminidas
na
inhibit
assay
compon
indic
abl
prevent
bud
progeni
viru
cell
membran
therefor
impli
epiprogoitrin
progoitrin
epigoitrin
goitrin
play
antivir
activ
act
viru
neutral
associ
compon
viral
envelop
without
interf
viral
adsorpt
bud
base
ic
valu
obtain
cpe
inhibit
assay
activ
compound
vitro
order
progoitrin
goitrin
epigoitrin
epiprogoitrin
comprehens
comparison
minimum
concentr
exhibit
inhibit
inhibit
rate
minimum
investig
concentr
mgml
obtain
ha
assay
embryon
egg
activ
compound
ovo
similar
order
progoitrin
goitrin
epigoitrin
epiprogoitrin
compar
potenc
antivir
activ
monom
remark
differ
found
precursor
myrosinasederiv
product
epiprogoitrin
vs
epigoitrin
progoitrin
vs
goitrin
contrari
consider
discrep
observ
enantiom
epiprogoitrin
vs
progoitrin
epigoitrin
vs
goitrin
gap
antivir
potenc
progoitrin
epiprogoitrin
larger
goitrin
epigoitrin
senantiom
progoitrin
goitrin
claim
higher
activ
renantiom
epiprogoitrin
epigoitrin
impli
heteroaromat
chainr
main
function
group
isatidi
radix
deriv
glucosinol
isom
breakdown
product
cycliz
heteroaromat
chain
oxazolin
ring
obviou
influenc
function
stereogen
center
chiral
carbon
atom
heteroaromat
chain
epiprogoitrin
progoitrin
oxazolin
ring
epigoitrin
goitrin
import
structur
featur
chemic
biolog
point
view
lucki
enough
compon
found
safe
cell
embryo
conclus
experiment
result
indic
epiprogoitrin
progoitrin
epigoitrin
goitrin
isatidi
radix
deriv
glucosinol
isom
breakdown
product
could
neutral
influenza
viru
strain
thu
exhibit
antivir
efficaci
vitro
ovo
find
enrich
pharmacolog
mechan
research
develop
isatidi
radix
common
tradit
medicin
use
treat
influenza
mechanist
studi
impli
compon
inhibitori
effect
hemagglutinin
neuraminidas
thu
attach
viral
envelop
without
disturb
viral
adsorpt
bud
host
cell
suggest
contribut
critic
mode
antivir
action
compon
potenti
activ
influenza
viru
target
like
endonucleas
viral
polymeras
nucleoprotein
protein
need
futur
explor
accur
antivir
efficaci
low
toxic
epiprogoitrin
progoitrin
epigoitrin
goitrin
isatidi
radix
expect
use
promis
antivir
drug
resourc
consequ
valid
includ
vivo
evalu
clinic
trial
requir
introduc
research
practic
applic
howev
whether
glucosinol
enzymat
hydrolys
could
inhibit
influenza
virus
unknown
molecular
mechan
still
need
clarifi
investig
lix
nie
yanlin
wu
design
carri
experi
analyz
data
wrote
manuscript
zhong
dai
check
data
shuangcheng
edit
articl
author
approv
review
manuscript
none
